Over the last 12 months, Shuttle Pharmaceuticals Holdings insiders reported 4 buys totaling $182K and 3 sales totaling $505K across SEC Form 4 filings.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | HRT FINANCIAL LP10% | ▼ Sale | 83,149 | $4.48 | $373K | -100% | 2 tranches |
| Jul 10, 2026 | HRT FINANCIAL LP10% | ▲ Buy | 8,997 | $3.36 | $30K | +17.2% | 2 tranches |
| Jul 8, 2026 | HRT FINANCIAL LP10% | ▼ Sale | 29,111 | $3.45 | $100K | -35.8% | 2 tranches |
| Jul 6, 2026 | HRT FINANCIAL LP10% | ▼ Sale | 9,022 | $3.51 | $32K | -10% | — |
| Jul 2, 2026 | HRT FINANCIAL LP10% | ▲ Buy | 7,851 | $3.54 | $28K | +9.5% | — |
| Jul 1, 2026 | HRT FINANCIAL LP10% | ▲ Buy | 3,959 | $3.3 | $13K | +5% | — |
| Jun 30, 2026 | HRT FINANCIAL LP10% | ▲ Buy | 32,591 | $3.4 | $111K | +70.8% | 2 tranches |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $SHPH feed.